about
Urinary concentrations of benzophenone-type ultraviolet light filters and semen qualityClustering of retrospectively reported and prospectively observed time-to-pregnancySuccessive time to pregnancy among women experiencing pregnancy lossPregnancy-specific association of vitamin D deficiency and bacterial vaginosis.Violence and cardiovascular health: a systematic reviewCombination of Triple Therapy and Chronic PPI Use May Decrease Risk of Colonic Adenomatous Polyps in Helicobacter pylori Infection.Family and partner interpersonal violence among American Indians/Alaska NativesSocial network members' roles and use of mental health services among drug users in New York City.Autologous endometrial coculture biopsy: is timing everything?Adjunctive social media for more effective contraceptive counseling: a randomized controlled trial.Availability and scope of integrated screening for patients with Lynch syndrome.Early and total neonatal mortality in relation to birth setting in the United States, 2006-2009.Apgar score of 0 at 5 minutes and neonatal seizures or serious neurologic dysfunction in relation to birth setting.Time-Varying Effects of Signs and Symptoms on Pregnancy Loss <20 Weeks: Findings from a Preconception Prospective Cohort Study.ReplyClustering of Retrospectively Reported and Prospectively Observed Time-To-Pregnancy Among Women in a Preconception CohortKnowledge of Lynch syndrome among obstetrician/gynecologists and general surgeonsFetal Ultrasound Parameters Predict the Neonatal Body Mass IndexMo1142 Combination of Triple Therapy and Chronic Proton Pump Inhibitor May Attenuate the Risk of Colonic Adenomatous Polyps in Helicobacter pylori InfectionApgar Score of 0 at 5 Minutes and Neonatal Seizures or Serious Neurologic Dysfunction in Relation to Birth Setting601: Neutrophil gelatinase-associated lipocalin as a diagnostic marker for preeclampsia690: Equivalence of erythromycin and azithromycin for treatment of PPROM
P50
Q28390261-A1B44BF7-56B5-413D-A861-DF81AC7C28EAQ28393401-1D25488B-74D4-4B7A-B499-4177D15E4E63Q28395595-6DB84D63-5BD5-4B8F-8CA0-A71FC59CDD1EQ34623995-E0862D73-4225-4E35-BE38-1DB2FC4DF6DAQ34990344-4C38E522-CFE7-4504-95E5-8777EB95D0BAQ35646634-E1B4A85E-445C-4F2C-B008-41A4CD3FF4EBQ37219112-5B5E78E4-044E-4AC5-9A0E-3BA88B1D1DE9Q37507750-9739275F-D803-4591-85EC-CA56201402C2Q39004922-539D68B1-E90B-4399-BD0C-56B31A977C0CQ40188009-B3D6BB3B-C4B0-4B0A-A4EB-560478148DEFQ40543913-17C7D429-1FA2-43BA-B01B-50DB53DED593Q44835330-8BD4F790-73FF-4AD6-8F90-3E106FBB2350Q46060510-B07EC523-8CA1-4341-B0B4-4CB990588057Q48238362-50BA2D31-ACF6-4102-8D80-7B7CA5F00A71Q59281155-F9B4C074-A9EB-4192-BF65-C71108F6A45AQ59281162-688EF3C8-AAE9-495B-AB57-22E1D8BB4A5DQ59281170-8F3C295A-269B-4F70-9281-A8B8997CC5F6Q59281171-6E1A0819-4850-4AEF-8811-4D6C9FC709B2Q59281172-35FB8972-57B6-44B8-8F47-A5E96980CAE7Q59281175-943FCB1A-B973-4128-B213-917E01844C37Q59281179-F9A79F56-5B2B-4167-AADC-1D5A4CC368E7Q59281181-2CFCDA12-1ECD-4724-BBDD-772957452334
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Katherine J Sapra
@ast
Katherine J Sapra
@en
Katherine J Sapra
@es
Katherine J Sapra
@fr
Katherine J Sapra
@nl
Katherine J Sapra
@sl
type
label
Katherine J Sapra
@ast
Katherine J Sapra
@en
Katherine J Sapra
@es
Katherine J Sapra
@fr
Katherine J Sapra
@nl
Katherine J Sapra
@sl
altLabel
KJ Sapra
@en
Katherine J Hensel
@en
Katherine J Sapra
@en
prefLabel
Katherine J Sapra
@ast
Katherine J Sapra
@en
Katherine J Sapra
@es
Katherine J Sapra
@fr
Katherine J Sapra
@nl
Katherine J Sapra
@sl
P106
P21
P31
P496
0000-0001-5659-6489